Search
24 Mar Alberto Garcia-Basteiro successfully defends tuberculosis thesis
Four years of intense work, research and analysis have paid off for Alberto Garcia-Basteiro: he successfully defended his thesis yesterday. Alberto first joined AIGHD in 2015 as a PhD candidate under the supervision of Executive Board Chair prof. Frank Cobelens and Dr. Sabine Hermans as...
20 Mar Study focuses on personalizing tuberculosis treatment to improve patient outcomes
Providing the most effective treatment to patients with multi-drug resistant tuberculosis (MDR-TB) – that’s the goal of a recently launched research project. As the leading cause of death from a single infectious agent, TB kills more people than HIV and AIDS, according to the World Health...
14 Mar Register for Towards Zero New Infections, a free global health symposium on infectious diseases
The Amsterdam Institute for Global Health and Development (AIGHD), Health[e]Foundation and the Amsterdam UMC are pleased to host a global health symposium focused on eliminating tuberculosis (TB), HIV and malaria transmission. Registration is free and now open. These major infectious diseases continue to be significant causes of ill health, despite global...
12 Mar Redefine world’s deadliest infectious disease to improve treatment and care
Defining diseases is crucial to effectively treating, researching and monitoring them. Current definitions for tuberculosis are outdated and categorize people with the disease into two categories: dormant (also called latent) infection, meaning they do not have an active form of the disease, and active infection....
08 Mar IWD 2019: Leading research to support innovation and equality for women and girls around the world
International Women’s Day is celebrated each year on March 8 and is a focal point in the movement to support women’s rights. This year’s theme is “Think equal, build smart, innovate for change” and puts innovation by women and girls, for women and girls, at...
07 Mar Starting antiretroviral treatment earlier doesn’t negatively impact adherence and disclosure
People who start antiretroviral treatment early, regardless of their CD4 count, are just as likely to stick to their treatment plan as those who begin their treatment when their CD4 count is low. The mixed methods paper led by the Amsterdam Institute for Global Health...
28 Feb Record number of abstracts received for INTEREST 2019
The annual INTEREST Conference is already making history – and it’s still months away. A record 613 abstracts were submitted through the open call, a 60% increase from last year. The HIV-focused conference takes place May 14-17 and for the first time, Ghana is the...
28 Jan AIGHD undertakes key research as part of innovative diabetes and hypertension project
Diabetes and hypertension are now key global threats. According to the World Health Organization, the number of people with diabetes rose to 422 million in 2014 and its prevalence is on the rise in low- and middle-income countries. Hypertension – high blood pressure – affects...